Whiteside TL - Search Results

1

Immune responses to malignancies.

Whiteside TL. Whiteside TL. J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S272-83. doi: 10.1016/j.jaci.2009.09.045. Epub 2010 Jan 12. J Allergy Clin Immunol. 2010. PMID: 20061007 Free PMC article. Review.

2

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.

Shimizu Y, Demetris AJ, Gollin SM, Storto PD, Bedford HM, Altarac S, Iwatsuki S, Herberman RB, Whiteside TL. Shimizu Y, et al. Among authors: whiteside tl. Int J Cancer. 1992 Sep 9;52(2):252-60. doi: 10.1002/ijc.2910520217. Int J Cancer. 1992. PMID: 1355757

3

Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.

Lotze MT, Zeh HJ 3rd, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herberman R. Lotze MT, et al. Among authors: whiteside tl. J Immunother (1991). 1992 Oct;12(3):212-7. doi: 10.1097/00002371-199210000-00015. J Immunother (1991). 1992. PMID: 1359903

4

Tumor-infiltrating lymphocytes as antitumor effector cells.

Whiteside TL. Whiteside TL. Biotherapy. 1992;5(1):47-61. doi: 10.1007/BF02194785. Biotherapy. 1992. PMID: 1389902 Review. No abstract available.

5

Extravasation of antitumor effector cells.

Whiteside TL, Herberman RB. Whiteside TL, et al. Invasion Metastasis. 1992;12(2):128-46. Invasion Metastasis. 1992. PMID: 1399401 Review.

6

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL. Rabinowich H, et al. Among authors: whiteside tl. J Immunol. 1992 Jul 1;149(1):340-9. J Immunol. 1992. PMID: 1535088

7

Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.

Whiteside TL, Jost LM, Herberman RB. Whiteside TL, et al. Crit Rev Oncol Hematol. 1992 Jan;12(1):25-47. doi: 10.1016/1040-8428(92)90063-v. Crit Rev Oncol Hematol. 1992. PMID: 1540337 Review. No abstract available.

8

Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.

Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL. Rabinowich H, et al. Among authors: whiteside tl. Cell Immunol. 1991 Jul;135(2):454-70. doi: 10.1016/0008-8749(91)90290-r. Cell Immunol. 1991. PMID: 1709827

9

Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.

Sedlmayr P, Rabinowich H, Elder EM, Ernstoff MS, Kirkwood JM, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: whiteside tl. J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005. J Immunother (1991). 1991. PMID: 1790141

10

Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.

Whiteside TL. Whiteside TL. In Vivo. 1991 Nov-Dec;5(6):553-9. In Vivo. 1991. PMID: 1810438 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results